RecruitMe Clinical Trial

Lumateperone (ITI-007) for Schizophrenia
Lumateperone for Schizophrenia
Sponsor:Intra-Cellular Therapies
Enrolling:Male and Female Patients
Study Length:199 Days
Clinic Visits:12
Age Range:Between 18 and 60 years old
IRB Number:7716
U.S. Government ID:NCT03817528
Contact: Marlene Carlson, MPH: 646-774-8436 / mc157@columbia.edu
Additional Study Information:

This study plans to learn more about an investigational new drug called lumateperone tosylate (ITI-007) and may help us find new types of treatment for schizophrenia and schizoaffective disorder.

Do You Qualify?
Do you have schizophrenia or schizoaffective disorder?YesNo
Are you between the ages of 18-60?YesNo
Have you used another investigational medication in the previous 4 weeks?YesNo
Submit
Cancel
Investigator
Jeffrey Lieberman, M.D.
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Marlene Carlson, MPH
Email: mc157@columbia.edu
Phone: 646-774-8436